Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2020

Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, “Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2020 provides comprehensive information about the Metered Dose Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Metered Dose Inhaler Devices delivers a specific amount of medication to lungs and GI tract. It is mostly used by asthma and COPD patients.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Metered Dose Inhaler Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Metered Dose Inhaler Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Metered Dose Inhaler Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Metered Dose Inhaler Devices Overview
  • Products under Development
    • Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
      • Table figure 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
      • Table Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
    • Metered Dose Inhaler Devices - Pipeline Products by Territory
      • Table figure 2: Metered Dose Inhaler Devices - Pipeline Products by Territory
      • Table Metered Dose Inhaler Devices - Pipeline Products by Territory
    • Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
      • Table figure 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
      • Table Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
    • Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
      • Table figure 4: Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
      • Table Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
    • Metered Dose Inhaler Devices - Ongoing Clinical Trials
      • Table figure 5: Metered Dose Inhaler Devices - Ongoing Clinical Trials
      • Table Metered Dose Inhaler Devices - Ongoing Clinical Trials
  • Metered Dose Inhaler Devices - Pipeline Products under Development by Companies
    • Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
      • Table Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
    • Metered Dose Inhaler Devices – Companies Pipeline Products by Stage of Development
      • Table Metered Dose Inhaler Devices – Companies Pipeline Products by Stage of Development
  • Metered Dose Inhaler Devices Companies and Product Overview
    • Adamis Pharmaceuticals Corp Company Overview
      • Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beclomethasone MDI - Product Status
        • Table Beclomethasone MDI - Product Description
    • Aeropharm GmbH Company Overview
      • Aeropharm GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aeropharm GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table VAL050 pMDI Valve / Actuator - Product Status
        • Table VAL050 pMDI Valve / Actuator - Product Description
    • Aerophase Inc Company Overview
      • Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aerosol-Delivery System - NTM Respiratory Infection - Product Status
        • Table Aerosol-Delivery System - NTM Respiratory Infection - Product Description
        • Table Metered Dose Inhaler - Product Status
        • Table Metered Dose Inhaler - Product Description
    • AstraZeneca Plc Company Overview
      • AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breztri Aerosphere - Product Status
        • Table Breztri Aerosphere - Product Description
    • Bespak Europe Ltd Company Overview
      • Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table VAL020 Metered Dose Inhaler Valve - Product Status
        • Table VAL020 Metered Dose Inhaler Valve - Product Description
    • Circassia Group Plc Company Overview
      • Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fliveo - Product Status
        • Table Fliveo - Product Description
        • Table Fluticasone propionate/Salmeterol xinafoate pMDI - Product Status
        • Table Fluticasone propionate/Salmeterol xinafoate pMDI - Product Description
        • Table Circassia Group Plc - Ongoing Clinical Trials Overview
        • Table Fluticasone propionate/Salmeterol xinafoate pMDI - A Phase III Registration Study of Seretide Substitute (PSX2005)
    • Globe Medical Tech Inc (Inactive) Company Overview
      • Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inhaler - Product Status
        • Table Inhaler - Product Description
    • GoFire Inc Company Overview
      • GoFire Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GoFire Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gofire Inhaler - Product Status
        • Table Gofire Inhaler - Product Description
    • Lab Automate Technologies Inc Company Overview
      • Lab Automate Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lab Automate Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ultrasonic Metered Dose Inhaler - Product Status
        • Table Ultrasonic Metered Dose Inhaler - Product Description
    • Lupin Pharmaceuticals Inc Company Overview
      • Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Albuterol MDI - Product Status
        • Table Albuterol MDI - Product Description
    • Medicom Innovation Partner a/s Company Overview
      • Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview
        • Table Asmair - Product Status
        • Table Asmair - Product Description
    • Nemera La Verpilliere Company Overview
      • Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview
        • Table RetroNose - Product Status
        • Table RetroNose - Product Description
    • Pearl Therapeutics Inc Company Overview
      • Pearl Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pearl Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PT001 - Product Status
        • Table PT001 - Product Description
        • Table PT010 - Product Status
        • Table PT010 - Product Description
    • Reciprocal Labs Corp Company Overview
      • Reciprocal Labs Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Reciprocal Labs Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Connected Metered Dose Inhaler - Product Status
        • Table Connected Metered Dose Inhaler - Product Description
    • Rensselaer Polytechnic Institute Company Overview
      • Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bloom Inhaler - Product Status
        • Table Bloom Inhaler - Product Description
    • Vectura Group Plc Company Overview
      • Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flutiform pMDI - Product Status
        • Table Flutiform pMDI - Product Description
    • Verona Pharma Plc Company Overview
      • Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RPL554 - Metered Dose Inhaler - Product Status
        • Table RPL554 - Metered Dose Inhaler - Product Description
        • Table Verona Pharma Plc - Ongoing Clinical Trials Overview
        • Table RPL554 - Metered Dose Inhaler - A Phase II, Randomized Study to Assess the Pharmacokinetics, Safety and Pharmacodynamics of Single and Repeat Doses of RPL554 Administered by Pressurised Metered Dose Inhaler in Patients with COPD
        • Table RPL554 - Metered Dose Inhaler - Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD
  • Metered Dose Inhaler Devices- Recent Developments
    • Jun 25, 2020: SEC charges Novartis with FCPA violations
    • Apr 15, 2020: Proveris Scientific announces joint scientific poster presentation with H&T Presspart at RDD 2020 Digital Conference
    • Mar 12, 2020: October 2019 saw a major milestone for H&T Presspart's revolutionary Plasma MDI canister with sales passing 100,000,000 cans.
    • Feb 11, 2020: Cannabix Technologies appoints VP of Technology Development
    • Feb 05, 2020: Merck announces fourth-quarter and full-year 2019 financial results
    • Feb 05, 2020: Merck to focus on key growth pillars through spinoff of women's health, trusted legacy brands and biosimilars products into new company ("newco")
    • Jan 31, 2020: Dr. Christine Seidman and Kathy Warden elected to Merck Board of Directors
    • Jan 29, 2020: Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019
    • Jan 28, 2020: Aptar Pharma partners with Lupin to launch India's First Connected Smart Device for Respiratory Disease, ADHERO
    • Jan 22, 2020: AstraZeneca's `Ambition Zero Carbon' strategy to eliminate emissions by 2025 and be carbon negative across the entire value chain by 2030
    • Jan 22, 2020: Novartis establishes its new legal entity in Vietnam
    • Jan 07, 2020: Temporary permission granted to advertise puffers and other inhalers with salbutamol
    • Dec 18, 2019: Pfizer and Mylan announce two future Viatris board members
    • Dec 16, 2019: Aptar Pharma to highlight drug delivery solutions portfolio and expanded services offering at Pharmapack 2020
    • Dec 05, 2019: Novartis expects to sustain long-term growth with a robust pipeline of 25+ potential blockbusters highlighted at R&D Day
    • Dec 03, 2019: Consort Medical: Interim results of 2019
    • Nov 22, 2019: Lupin launches "Adhero," first-of-its-kind connected Smart Device in India to support treatment of Respiratory Disease
    • Nov 14, 2019: Gofire launches patented, metered-dose inhaler to vaporization market seeking safe, accurate dose control
    • Nov 12, 2019: Monaghan Medical wins prestigious Zenith Award from the American Association of Respiratory Care
    • Nov 12, 2019: Mylan and Pfizer announce Viatris as the new company name in the planned Mylan-Upjohn combination
    • Nov 05, 2019: Mylan reports third quarter 2019 results and updates 2019 guidance
    • Oct 29, 2019: Merck announces third-quarter 2019 financial results
    • Oct 29, 2019: Vectura Group appoints New Chief Executive Officer
    • Oct 22, 2019: Novartis delivered another strong quarter with double digit sales growth and core1 margin expansion; 2019 sales and profit guidance raised; Beovu launched in US
    • Sep 26, 2019: Vectura Group: Board Change
    • Sep 13, 2019: Vectura provides update on GSK Litigation
    • Sep 10, 2019: Vectura Group interim results for the six months ended 30 June 2019
    • Sep 10, 2019: Vectura delivers strong financial performance for H1 2019 and confirms proposed special dividend of approximately £40m in aggregate plus a £20m buyback programme
    • Aug 26, 2019: Change in the board of managing directors at Boehringer Ingelheim
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook